Non-Therapeutic Protocol

GENEFU: Long-Term Follow-Up of Patients who have Received Gene Therapy/Gene Marked Products

Type of Protocol/Clinical Study

Associated Stem Cell Transplant Studies

Description

Gene transfer is a relatively new area of science and medicine. Physicians want to make sure the use of gene transfer is safe when given as part of research or treatment for disease. Because gene transfer is a newly developing area of medicine, little is known about the effects that these treatments might have long after their use. 

Government agencies recommend that all recipients of gene transfer be monitored for 15 years after receiving a gene transfer product. This study will follow children who have received a gene transfer product at St. Jude Children’s Research Hospital within the past 15 years. The study will include physical evaluations and blood tests that will be performed at least once a year, for the 15 year period.  The information gathered in this research study will serve as case history data for the detection of late clinical effects associated with the use of gene transfer therapies.


Objectives


Eligibility

Only current St. Jude patients are eligible.

Principal Investigator

Brian Sorrentino, MD

The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.